It seems that only "questionable" companies were the only ones willing to partner with GNBT to the detriment of shareholders. Due diligence was never GNBT's strong suit no matter who was at the helm. The only consistent outcome of every leadership regime at GNBT was poor decisions that led to big losses for investors.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links